Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTracsis Regulatory News (TRCS)

Share Price Information for Tracsis (TRCS)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -5.00 (-1.52%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £96.78m
TRCS Live PriceLast checked at - London Stock Exchange

Intraday Tracsis Share Chart

Director/PDMR Shareholding

17 Jul 2014 07:54

RNS Number : 5781M
Tracsis PLC
17 July 2014
 



 

Tracsis plc

 

("Tracsis" or the "Company")

 

Directors Dealing - Exercise of Options

 

Tracsis announces that it received on 16 July 2014, notice of exercise of options from the following Directors:

 

John McArthur, Chief Executive Officer, exercised 140,000 options at an exercise price of 52p per share from a share option agreement dated 2009. No shares were sold in order to satisfy exercise costs. As a result of this, Mr McArthur's interests in the company increased to 1,112,474 representing 4.2% of the total voting rights of the Company.

 

Max Cawthra, Finance Director, exercised 75,000 options at an exercise price of 49.5p per share from a share option agreement dated 2011. In order to satisfy exercise costs 25,000 shares were subsequently disposed at a price of £3.11. As a result of this transaction, Mr Cawthra's interests in the company increased from 4,000 to 54,000 representing 0.2% of the total voting rights of the Company.

 

Charles Winward, a Non-Executive Director exercised 87,517 options at an exercise price of 40p per share from a share option agreement dated 2007. In order to satisfy exercise costs, income tax, national insurance and other liabilities arising 57,246 shares were subsequently disposed at a price of £3.11. As a result of this transaction Mr Winward's interests in the company will increase from 56,500 to 86,771 representing 0.3% of the total voting rights of the Company.

 

A summary of these transactions and resulting Directors' holdings in Tracsis is as follows:

 

Share holding prior to exercise

Option holding prior to exercise

Options exercised today

Shares sold today

Resulting Share

Holding

% of issued share capital

Non-Executive Directors

Chris Cole (Chair)

-

-

-

-

-

-

Sean Lippell

-

50,000

-

-

-

-

John Nelson

230,824

25,000

-

-

230,824

0.9%

Charles Winward

56,500

137,517

87,517

(57,246)

86,771

0.3%

Executive Directors

Max Cawthra

4,000

235,162

75,000

(25,000)

54,000

0.2%

John McArthur

972,474

240,000

140,000

-

1,112,474

4.2%

Total Interest

1,263,798

687,679

302,517

(82,246)

1,484,069

5.6%

 

 

Accordingly, the Company has today issued 302,517 ordinary shares in the Company "new ordinary shares". Application has been made for the new ordinary shares to be admitted to trading on AIM and dealings are expected to commence on 22 July 2014.

 

Following the issue of the new shares, the number of Ordinary Shares in issue will increase to 26,258,114. For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following this allotment consists of 26,258,114 Shares with voting rights attached (one vote per Share). There are no shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, Tracsis under the DTRs.

 

 

For more information please contact:

 

John McArthur/Max Cawthra, Tracsis plc

 

Tel: 0845 125 9162

Katy Mitchell, WH Ireland Limited

Tel: 0161 832 2174

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKMGMNVNFGDZG
Date   Source Headline
19th Feb 202511:37 amRNSHolding(s) in Company
19th Feb 20257:00 amRNSContract signed for Tap Converter system
5th Feb 20255:09 pmRNSHolding(s) in Company
3rd Feb 20257:00 amRNSTotal Voting Rights
29th Jan 20257:00 amRNSScotRail expands Tap&Pay smart ticketing app
23rd Jan 202511:49 amRNSAward of Options
22nd Jan 20254:32 pmRNSResult of AGM
2nd Jan 20259:12 amRNSTotal Voting Rights
18th Dec 20247:00 amRNSDirector/PDMR Shareholding
12th Dec 202412:23 pmRNSNotification of Transactions by PDMR
6th Dec 20247:00 amRNSAnnual Report and Notice of AGM
2nd Dec 20247:00 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSPreferred bidder for PAYG Tap Converter system
20th Nov 20247:00 amRNSFinal Results
8th Nov 20247:00 amRNSAppointment of Nominated Adviser
1st Nov 20247:00 amRNSTotal Voting Rights
9th Oct 202412:57 pmRNSHolding(s) in Company
1st Oct 20247:00 amRNSTotal Voting Rights
2nd Sep 20247:01 amRNSBlock Listing Return
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Aug 20247:00 amRNSTrading Update and Notice of Results
1st Aug 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTotal Voting Rights
21st Jun 20247:00 amRNSAIM Rule 17 Update
13th Jun 20247:00 amRNSTrading Update
3rd Jun 20247:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 202412:35 pmRNSDirector/PDMR Shareholding
24th Apr 20247:00 amRNSInterim Results
9th Apr 20245:43 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
11th Mar 20247:30 amRNSAppointment of Joint Broker
11th Mar 20247:00 amRNSBoard Changes
5th Mar 202411:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
1st Mar 20247:02 amRNSListing Application
1st Mar 20247:01 amRNSBlock Listing Return
1st Mar 20247:00 amRNSTotal Voting Rights
22nd Feb 20247:00 amRNSTrading Update and Notice of Results
1st Feb 20247:00 amRNSTotal Voting Rights
24th Jan 20246:05 pmRNSResult of AGM
9th Jan 20247:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
2nd Jan 20247:00 amRNSTotal Voting Rights
8th Dec 20238:25 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSAnnual Report and Notice of AGM
6th Dec 20237:00 amRNSGrant of Options
1st Dec 20237:00 amRNSTotal Voting Rights
15th Nov 20237:00 amRNSFinal Results
1st Nov 20237:00 amRNSTotal Voting Rights
2nd Oct 20237:00 amRNSTotal Voting Rights
25th Sep 202311:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.